Dexcom CEO Kevin Sayer to step down
Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.
New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit
George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a second FDA division to his portfolio after Vinay Prasad’s sudden departure.
New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit Read More »
UHS posts softer-than-expected volumes for second consecutive quarter
In light of the results, executives backed away from prior behavioral health growth targets for 2025, though they slightly raised the midpoint of overall revenue guidance.
UHS posts softer-than-expected volumes for second consecutive quarter Read More »
Exit Stage Right: With Prasad Out, Analysts Hope for More Traditional Replacement
As analysts parsed news of Vinay Prasad’s ouster, worries over drug approval delays, cell and gene therapy impacts and more were top of mind.
Exit Stage Right: With Prasad Out, Analysts Hope for More Traditional Replacement Read More »
Medicare Part D premiums likely to increase next year
The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS.
Medicare Part D premiums likely to increase next year Read More »
Nueva técnica para el análisis serológico masivo
Los métodos actuales para detectar anticuerpos, como los ensayos serológicos convencionales, tienen limitaciones en cuanto a la cantidad de información que pueden procesar en una sola prueba. Aunque técnicas más recientes han permitido ampliar el número de m …
Nueva técnica para el análisis serológico masivo Read More »
Medtech firms slash expected tariff charges
This earnings season, top medical device companies have dramatically reduced their expectations for tariff impacts in 2025. Check out MedTech Dive’s coverage.
Elevance names former Cencora CEO to board
Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to build out its pharmacy services.
El inesperado papel de un tipo de célula en la metástasis hepática
En un estudio reciente, se ha descubierto que la metástasis hepática desaparece casi por completo cuando se elimina cierto tipo de célula activada por el cáncer. Los ensayos realizados en ratones muestran que las células estrelladas del hígado, que por s&iac …
El inesperado papel de un tipo de célula en la metástasis hepática Read More »
Judge halts Arkansas law forcing PBMs to sell pharmacies
U.S. District Judge Brian Miller agreed with pharmacy benefit managers that the state’s law may violate the Constitution in granting their request for a preliminary injunction.
Judge halts Arkansas law forcing PBMs to sell pharmacies Read More »